ORLANDO, USA: Infosys, a global leader in technology, consulting and outsourcing, has launched a cloud-based version of its Clinical Trial Supply Management (CTSM) solution.
The new solution helps life sciences companies enhance efficiency of clinical trial processes by driving greater collaboration between pharmaceutical companies and contract research organizations (CROs).
This solution helps to improve the productivity of the overall drug development process. It also helps ensure the timely and accurate supply of drugs to patients at reduced costs. As a result, enterprises can price products competitively while adhering to the stringent standards required to bring products safely to consumers.
The new cloud-based version of the CTSM solution is an enhancement to the existing on-premise version of the CTSM solution - CTSM Add-On Suite 2.2 by Lodestone - that offers a complete set of tools to manage all aspects of complex clinical trials. This covers demand and supply planning as well as distribution across clinical sites. The on-premise version of the solution has been successfully managing clinical trial processes at a number of large global pharmaceutical companies across the U.S. and Europe.
Highlights:
· The new cloud-based version of the CTSM solution offers increased visibility across the clinical trial supply chain - driving greater manufacturing and warehouse efficiencies while further ensuring compliance. For example, enterprises can respond faster to changes in demand based on actual enrollment and patient turnaround during trials
· The solution integrates easily with existing enterprise resource planning (ERP) systems, incorporating business processes and other unique requirements of clinical trials
· Available on a pay-per-use basis, it will help pharmaceutical, biotech companies and CROs eliminate the need to invest in or manage expensive infrastructure dedicated to clinical trial management
· With mobility-enabled transactions and remote access capabilities, the solution facilitates real-time data entry for faster decision making
· The intuitive user interface helps users easily perform key business functions using version 5 of SAP's user interface and encourages wider adoption of the solution
The CTSM Add-On Suite 2.2 by Lodestone has been certified by SAP as powered by the SAP NetWeaver technology platform. The on-premise solution is now owned by Infosys, following its acquisition of Lodestone in 2012.
A recent Gartner report stated that "end-to-end business processes for CTSCs tend to be highly fragmented, span multiple functions and involve multiple enterprises. Clinical trials are growing in scale and complexity, driving a need for business processes and systems that integrate the end-to-end activities, decisions and information across business functions."
Infosys will be demonstrating the cloud-based version of CTSM and other solutions in booth #308 at the SAPPHIRE NOW conference being held June 3-5 in Orlando.